Sight Sciences Stock

sightsciences.comHealthcare / Medical DevicesFounded: 2010Funding to Date: $180MM

Sight Science was created in 2010, focusing on developing and commercializing innovative solutions to transform care and improve patients' lives. Targeting eye diseases and using minimally invasive or non-invasive approaches positively impacts a patient's sight. By implementing these techniques, Sight Sciences can address the underlying causes of the world's most prevalent eye disease.

Register To Buy and Sell Private Company Shares

For more details on financing and valuation of private companies similar to Sight Sciences before its IPO, register or login today.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value

Powered by Forge Data

Access valuation and stock price for companies like Sight Sciences before its IPO.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Sight Sciences’ stock FAQs


Can you buy Sight Sciences’ stock?

You can no longer buy Sight Sciences’ stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.

How to buy Sight Sciences’ stock?

To invest in a private company like Sight Sciences’ through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)
  1. Create a free account to access Forge's marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Sight Sciences’ stock?

You can no longer sell stock of Sight Sciences on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.

How to sell Sight Sciences’ stock?

If you hold private company shares of Sight Sciences’ - whether as an employee or an early investor - Forge can help you sell them.
  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your Sight Sciences’ on our platform.
  3. Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.

Is Sight Sciences’ a public company?

No, Sight Sciences’ is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Sight Sciences’ stock price?

The stock price of Sight Sciences is $5.21 as of 1/18/24.

What is Sight Sciences’ stock ticker symbol?

The ticker symbol of Sight Sciences is SGHT.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.


Management Team

Jesse Selnick
Chief Financial Officer
Shawn O'Neil
Chief Commercial Officer
Paul Badawi
Co-Founder, President, Chief Executive Officer & Board Member
David Badawi MD
Co-Founder, Chief Technology Officer & Board Member
Reay Brown
Chief Medical Officer

Board Members

David Badawi MD
Valeska Schroeder Ph.D
Mack Hicks
Hicks Equity Partners
Paul Badawi
Carter Meyer JD
Scientific Health Development
Tommy Hicks


Sight Sciences Appoints Erica Rogers to its Board of Directors

Sight Sciences announced the appointment of Erica Rogers to the company’s board of directors. Ms. Rogers, President and CEO of Silk Road Medical, is an experienced leader and entrepr

Sight Sciences Raises $56M in Funding | FinSMEs

Sight Sciences, a medical device company focused on ophthalmology and optometry, glaucoma and dry eye disease, closed a $31m in Series D financing
Updated on: Jul 23, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.